Full video transcriptClick to expand
Auto-generated transcript of @user6976169776594's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:01Here we go with the good old doctors again. Currently on 125 milligrams a week, bloods came back good T levels at
- 0:08165 doc says they're too high. What are your thoughts?
- 0:11My thoughts are you need to tell doctor kiss your ass and if he's got something to say after that go find a new doctor because
- 0:171600 is not too high you are high yes, but you are still high normal
- 0:21Okay, you're barely just over high normal and it's nothing you should be worried about or your doctor should be worried about
- 0:27As long as you stay up on blood work you stay consistent with your blood work
- 0:31Then being at that level is not going to cause any type of dramatic issues
- 0:35Unless you have underlying issues or your body is just not responding well
- 0:40How do I know this because I keep my testosterone levels at
- 0:432800 and I have for a very long period of time and my blood work always comes back perfectly fine
- 0:48This is yet another reason why I cannot stand doctors sometimes because they are too worried about fucking numbers
- 0:54And they are not worried about treating the goddamn symptoms
- 0:57Which is what put you in his office in the first place
- 0:59Let me guess the same doctor doesn't even have you prescribed any type of ais at least to keep on hand in case your
- 1:04Estrogen starts to climb up. I wouldn't be surprised now 99% of the time
- 1:09I'm never gonna tell you, you know, don't listen to your doctor or don't follow his advice and to be perfectly clear
- 1:14I'm not really saying that right now. I'm just saying that if your doctor thinks that 1100
- 1:191165 is gonna be too high
- 1:21It might be time to start considering a new doctor if he's not going to treat your symptoms because he's too worried about some damn numbers
- 1:27Hopefully that helps you out gives you some advice man. I wish you the best of luck and I appreciate your question
How much muscle can you actually gain on TRT in year one?
Quick answer
The viewer described in this video is on 125 mg of testosterone per week and tested at 1,165 ng/dL total testosterone, which is above standard reference ranges used by most U.S. clinical labs. The creator's own disclosed level of 2,800 ng/dL represents significant supraphysiologic testosterone, a range associated with erythrocytosis risk and cardiovascular monitoring requirements that go beyond a standard blood panel. Any decision to adjust testosterone dosing or switch providers should involve a licensed clinician reviewing full labs including hematocrit, estradiol, PSA, and lipid panels.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For How much muscle can you actually gain on TRT in year one?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
How much muscle can you actually gain on TRT in year one? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "How much muscle can you actually gain on TRT in year one?" from @hubchineuro. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The viewer described in this video is on 125 mg of testosterone per week and tested at 1,165 ng/dL total testosterone, which is above standard reference ranges used by most U.
The reason this review is not generic is the source wording and the canonical claim label "trt how much muscle can you gain on trt the first year trt testo." In this clip, the useful excerpt is: "Here we go with the good old doctors again." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The viewer described in this video is on 125 mg of testosterone per week and tested at 1,165 ng/dL total testosterone, which is above standard reference ranges used by most U.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The viewer described in this video is on 125 mg of testosterone per week and tested at 1,165 ng/dL total testosterone, which is above standard reference ranges used by most U.S. clinical labs. The creator's own disclosed level of 2,800 ng/dL represents significant supraphysiologic testosterone, a range associated with erythrocytosis risk and cardiovascular monitoring requirements that go beyond a standard blood panel. Any decision to adjust testosterone dosing or switch providers should involve a licensed clinician reviewing full labs including hematocrit, estradiol, PSA, and lipid panels.
- The Endocrine Society's 2018 clinical practice guidelines recommend targeting 400 to 700 ng/dL during TRT for most men, not supraphysiologic levels.
- The TRAVERSE trial (Lincoff et al., 2023, NEJM) studied cardiovascular safety of testosterone therapy at therapeutic doses, not at the 2,800 ng/dL level the creator describes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Endocrine Society's 2018 clinical practice guidelines recommend targeting 400 to 700 ng/dL during TRT for most men, not supraphysiologic levels.
- The TRAVERSE trial (Lincoff et al., 2023, NEJM) studied cardiovascular safety of testosterone therapy at therapeutic doses, not at the 2,800 ng/dL level the creator describes.
- Hematocrit elevation is one of the most consistent dose-dependent risks of testosterone therapy and requires specific monitoring beyond a basic metabolic panel.
- A doctor flagging a testosterone level above 1,100 ng/dL is acting within established clinical guidelines, not simply being overly cautious.
- Aromatase inhibitors are not a standard first-line add-on in TRT and carry their own risks including bone density loss and suppressed estradiol when overused.
- The creator's personal experience at 2,800 ng/dL is anecdotal and unverifiable. Standard blood panels do not rule out all harms associated with supraphysiologic testosterone.
- Seeking a second opinion from a licensed clinician experienced in TRT is reasonable. Adjusting or abandoning medical care based on social media advice is not.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @user6976169776594 actually say?
The creator is responding to a viewer who says their doctor flagged testosterone levels of 1,165 ng/dL as too high while on 125 mg of testosterone per week. The creator's advice: tell the doctor to "kiss your ass" and find a new one. Their reasoning is that 1,165 is "barely just over high normal" and shouldn't cause problems as long as blood work stays consistent. They also disclosed that they personally maintain levels of 2,800 ng/dL and claim their blood work "always comes back perfectly fine." They criticized the doctor for focusing on numbers rather than symptoms, and questioned why no aromatase inhibitor (AI) was prescribed. While they stopped short of explicitly saying to ignore the doctor, the message was clear.
The creator's frustration with symptom-blind medicine has real merit in some corners of TRT practice. But the specific claims about what testosterone levels are "safe" deserve serious scrutiny.
Does the science back this up?
Partly, but not in the way the creator implies. The claim that 1,165 ng/dL is harmless with consistent monitoring has some clinical support, but 2,800 ng/dL is a different conversation entirely, and conflating the two is a problem.
The normal physiologic range for total testosterone in adult males is typically 300 to 1,000 ng/dL, with some labs extending the upper limit to 1,050 or 1,100 ng/dL. A level of 1,165 ng/dL is above reference range but not dramatically so. Studies on testosterone therapy, including Bhasin et al. (2010, New England Journal of Medicine), suggest that supraphysiologic levels do carry dose-dependent risks, including erythrocytosis, cardiovascular stress, and suppression of endogenous production. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found that testosterone therapy in middle-aged and older men did not significantly increase major cardiovascular events at therapeutic doses, but participants were not being maintained at 2,800 ng/dL.
The creator's personal claim of running 2,800 ng/dL long-term with clean labs is unverifiable and pharmacologically unusual. At that level, hematocrit elevation and cardiovascular strain are well-documented concerns that do not always show up in a standard metabolic panel.
What did they get wrong (or right)?
They got one thing right: doctors who refuse to treat symptoms because a number falls slightly outside a reference range are a genuine problem in TRT care. The literature supports individualized treatment, and a blanket refusal at 1,165 ng/dL without clinical context is arguably too rigid.
But here is what they got wrong. First, equating 1,165 ng/dL with 2,800 ng/dL as similarly manageable is not supported by evidence. These are meaningfully different physiologic states. Second, the suggestion that "blood work always comes back fine" at 2,800 ng/dL ignores that standard panels often miss early polycythemia risk, left ventricular changes, or lipid shifts that require specialized testing. Shabsigh et al. (2005, BJU International) noted that hematologic and cardiovascular parameters need specific monitoring at supraphysiologic levels, not just a routine panel. Third, the AI advice, while not entirely wrong as a concept, is delivered without any nuance about when AIs are actually appropriate, and blanket AI use has its own risks including bone density loss and libido suppression.
What should you actually know?
If your testosterone level on TRT is modestly above the reference range and you feel well, a conversation about the risks and benefits with an informed physician is reasonable. Immediately dismissing a doctor over a cautious reading is not.
Reference ranges exist for a reason, even if they are imperfect. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal physiologic levels during TRT, roughly 400 to 700 ng/dL, for most men. Levels above 1,000 ng/dL are associated with increased erythrocytosis risk, and hematocrit should be checked before and during therapy. A doctor flagging 1,165 ng/dL is not necessarily being unreasonable. They may be doing their job. The appropriate response is a conversation, not a dismissal. Seeking a second opinion from a TRT-experienced clinician is a reasonable step. Taking dosing cues from a TikTok creator who runs 2,800 ng/dL and frames it as no big deal is not.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
@hubchineuro · TikTok creator
1.0K views on this video
How much muscle can you gain on TRT the first year #trt #testosterone #longevity #antiaging #foreveryoung #muscle #over40 #bodybuilding #Fitness #training #ifbbpro #diet #nutrition #gym #GymTok #GymLife #ripped less
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the endocrine society's 2018 clinical practice guidelines recommend targeting 400?
The Endocrine Society's 2018 clinical practice guidelines recommend targeting 400 to 700 ng/dL during TRT for most men, not supraphysiologic levels.
What does the video say about the traverse trial (lincoff et al., 2023, nejm) studied cardiovascular?
The TRAVERSE trial (Lincoff et al., 2023, NEJM) studied cardiovascular safety of testosterone therapy at therapeutic doses, not at the 2,800 ng/dL level the creator describes.
What does the video say about hematocrit elevation?
Hematocrit elevation is one of the most consistent dose-dependent risks of testosterone therapy and requires specific monitoring beyond a basic metabolic panel.
What does the video say about a doctor flagging a testosterone level above 1,100 ng/dl?
A doctor flagging a testosterone level above 1,100 ng/dL is acting within established clinical guidelines, not simply being overly cautious.
What does the video say about aromatase inhibitors?
Aromatase inhibitors are not a standard first-line add-on in TRT and carry their own risks including bone density loss and suppressed estradiol when overused.
What does the video say about the creator's personal experience at 2,800 ng/dl?
The creator's personal experience at 2,800 ng/dL is anecdotal and unverifiable. Standard blood panels do not rule out all harms associated with supraphysiologic testosterone.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by @hubchineuro, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.